Poster Abstract Session:
54. Bone and Joint Infections
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Pediatric ID, Trainee


Presentations:
285
Challenging The Dogmas Of Outpatient Parenteral Antimicrobial Therapy Through A Randomized Controlled Trial
Laila Ibrahim, MBBChBAO; Sandy Hopper, MBBS; Francesca Orsini, MSc; Andrew Daley, MBBS; Franz Babl, MD; Penelope Bryant, BM BCh, PhD
286
Rapid, One-Tier Diagnosis for Lyme Arthritis
Bazak Sharon, MD; Megan Reinhard, Undergraduate student; Mackenzie Diekmann, Medical Student; Liz Butler, Undergraduate student; Jeff Louie, MD
287
The Attributable Mortality of Prosthetic Joint Infection after Primary Hip and Knee Arthroplasty among Medicare Beneficiaries, 2005—2012
Kara Jacobs Slifka, MD, MPH; Sarah H. Yi, PhD; Sujan C. Reddy, MD; James Baggs, PhD; John A. Jernigan, MD, MS
288
Expediting discharge in acute bacterial skin and skin structure infections: a clinical and economic comparison between vancomycin and oritavancin
Cristen Whittaker, PharmD; Ethan Nhan, PharmD, CACP; Pavan Ganapathiraju, DO; Sandra Garrett, B.S.Pharm, MBA; Joseph Reilly, PharmD, BCGP; Manish Trivedi, MD
Posters
  • Poster_Number_288_IDSA.pdf (1.1 MB)
  • 289
    International Validation of a Methicillin-Resistant Staphylococcus aureus (MRSA) Risk Assessment Tool for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
    Evan J. Zasowski, PharmD, MPH; Trang D. Trinh, PharmD, MPH; Kimberly Claeys, PharmD, BCPS; Matthew Dryden, MD, FRCPath, FRCPS; Sergey Shlyapnikov, MD; Matteo Bassetti, MD, PhD; Alessia Carnelutti, MD; Nana Khachatryan, MD; Asok Kurup, MBBS, MMED; Abraham Pulido Cejudo, MD; Luiz Henrique Melo, MD; Bin Cao, MD; Michael J. Rybak, PharmD, MPH, PhD
    291
    Effect of Previous Antibiotic Exposure on the Yield of Bone Biopsy Culture in Patients with Osteomyelitis
    Andrew Simms, BS; Paul D. Fey, PhD; Elizabeth Lyden, MS; Angela Hewlett, MD, MS, FIDSA; Mark E. Rupp, MD
    294
    Spondylodiscitis after Spine Surgery: Microbiology, Clinical findings, Outcome and Comparison with Spontaneous Spondylodiscitis
    Uh Jin Kim, MD; Younggon Jung, M.D.; Tae Hoon Oh, MD; Ji Yun Bae, MD; Seong Eun Kim, MD; Chung-Jong Kim, MD; Seung-Ji Kang, MD; Hee-Chang Jang, MD; Sook-In Jung, MD; Kyoung-Ho Song, M.D., Ph.D.; Eu Suk Kim, PhD; Hong Bin Kim, M.D., Ph.D.; Wan Beom Park, M.D., Ph.D; Nam Joong Kim, M.D., Ph.D.; Kyung-Hwa Park, MD
    296
    Outcomes From a Novel Transition-of-Care OPAT Service Targeting Orthopedic Device-Related Infections
    Sidra Hassan, MD; Kelsie Cowman, MPH; Sandeep Ponnappan, PA-C; Theresa Madaline, MD; Priya Nori, MD
    Posters
  • IDWeek Poster-Sidra Hassan.pdf (489.8 kB)
  • 297
    Risk Factors for Infections in Open Fractures
    Sharon Reisfeld, MD; Islam Labnawi, MD; Nurit Shadmi, MD; Michal Stein, MD
    299
    Tolerance and serum concentration of cefepime used subcutaneously (SC) in the management of bone and joint infections.
    Addy Assaf, MD; Olivier Robineau, MD; Marie Titecat, MD PhD; Delphine Allorge, PharmD; Benjamin Hennart, PharmD; Caroline Loyez, MD; Henri Migaud, PH MD; Eric Senneville, MD, PhD
    300
    Armed to the teeth – human bite associated septic arthritis
    Stephen McBride, BHB, MBChB; Jessica Mowbray, MBChB; William Caughey, MBChB; Edbert Wong, MBChB; Christopher Luey, MBChB; Ahsan Siddiqui, MB BS; Zanazir Alexander, MBChB; Veronica Playle, MBChB; Timothy Askelund, MBChB; Christopher Hopkins, MD; Norman Quek, MBChB; Katie Ross, MBChB; David Holland, MBChB FRACP FRCPA PhD
    Posters
  • ID Week poster Armed_poster.pdf (578.8 kB)
  • 302
    Role of Inflammatory Markers in Diagnosing Diabetic Foot Infection: A Meta-analysis
    Aneela Majeed, MD; Adeela Mushtaq, MD; Ahmad Iftikhar, MD; Umar Zahid, MD; Fnu Sagar, MD; Muhammad Usman, MD; Muhammad Fraz, MD; Mayar Al Mohajer, MD
    Posters
  • Poster final .pdf (417.6 kB)
  • 304
    Comparison of Short and Long Courses of Antibiotics in Patients with Prosthetic Joint Infection: A Systemic Review and Meta-analysis
    Ronan Hsieh, M.D.; Hung-Teng Yen, M.S.; Chung-Yen Huang, M.S.; Chien-Chang Lee, M.D., Sc.D.
    Posters
  • PJI IDSA poster_Ronan Hsieh.pdf (611.1 kB)
  • 305
    Enterobacteriaceae native joint septic arthritis
    Boris Yow, MBChB; Stephen McBride, BHB, MBChB; Jessica Mowbray, MBChB; William Caughey, MBChB; Edbert Wong, MBChB; Christopher Luey, MBChB; Ahsan Siddiqui, MB BS; Zanazir Alexander, MBChB; Veronica Playle, MBChB; Timothy Askelund, MBChB; Christopher Hopkins, MD; Norman Quek, MBChB; Katie Ross, MBChB; David Holland, MBChB FRACP FRCPA PhD
    306
    Safety and Tolerability of Tedizolid as Oral Treatment for Bone and Joint Infections
    Bryn Launer, BA; Evelyn A. Flores, BS; Maita Kuvhenguhwa, MD; Tae Kim, MPH; Kelli Derrah, BA; Loren G. Miller, MD, MPH
    307
    Evaluation of the Diagnostic Approach to Native Spondylodiskitis
    Rachel Weihe, MD; Douglas Burton, MD; Sean Jackson, MD; Alan Reeves, MD; Duncan Rotich, MS; Jianghua He, PhD; Wissam El Atrouni, MD, MSc
    Posters
  • 307_IDWPOSTER.pdf (617.8 kB)
  • 308
    Identification of Prosthetic Hip and Knee Joint Infections in Administrative Databases
    Christopher Kandel, MD; J. Roderick Davey, MD; Nick Daneman, MD, MSc; Allison McGeer, MD, MSc
    309
    The Infected Spacer: The Impact of Spacer Exchanges and Debridements on Two-Stage Exchange Arthroplasty Outcomes
    Michael Henry, MD; Celeste Russell, MPH; Allina Nocon, PhD; Geoffrey Westrich, MD; Barry Brause, MD; Andy Miller, MD
    Posters
  • Final - Infected Spacer.pdf (306.3 kB)
  • 311
    Low Rate of Microbiologic Relapse in Two Stage Exchange for Knee Prosthetic Joint Infections
    Michael Henry, MD; Celeste Russell, MPH; Allina Nocon, PhD; Geoffrey Westrich, MD; Barry Brause, MD; Andy Miller, MD
    Posters
  • Final - Microrelapse.pdf (329.9 kB)
  • 312
    Comparison of Short Course and Long Course of Antibiotics in Patients with Osteomyelitis: A Systemic Review and Meta-analysis
    Ronan Hsieh, M.D.; Chung-Yen Huang, M.S.; Hung-Teng Yen, M.S.; Chien-Chang Lee, M.D., Sc.D.
    313
    Outpatient Treatment and Recurrence of Prosthetic Joint Infection (PJI) in Infectious Disease (ID) Physician Office Infusion Centers (POICs): A 2-Year Retrospective Multicenter Analysis.
    Brian S. Metzger, MD, MPH; John S. Adams, MD, FIDSA, FSHEA; Jorge R. Bernett, MD; Richard M. Mandel, MD, FIDSA; Richard C. Prokesch, MD, FACP, FIDSA; Carson T. Lo, MD; Thomas C. Hardin, PharmD; Claudia P. Schroeder, PharmD, PhD; Lucinda J. Van Anglen, PharmD
    315
    Oral versus intravenous antibiotic treatment for gram-positive prosthetic joint infections: a retrospective study.
    Alexandre Coehlo, Student; Olivier Robineau, MD; Marie Titecat, MD PhD; Sophie Putman, MD; Nicolas Blondiaux, PharmD PhD; Michel Valette, MD; Eric Beltrand, MD; Henri Migaud, PH MD; Eric Senneville, MD, PhD
    317
    Risk Factors for Fungal Prosthetic Joint Infections (PJIs)
    Talha Riaz, MD; Aaron Tande, M.D.; Lisa L Steed, PhD; Harry Demos, MD; Cassandra Salgado, MD, MS; Douglas Osmon, MD; Camelia Marculescu, MD
    318
    Treatment Outcomes of Prosthetic Joint Infections: An Internal Assessment of Adherence to Best Practice Guidelines
    Courtney Horvat, PharmD; Margaret Cook, PharmD; Katherine Torres, DO; Thomas J. Dilworth, PharmD; Charles F. Brummitt, MD
    Posters
  • IDWeek Poster PJI FINAL.pdf (857.7 kB)
  • 320
    Variation in use of chronic antibiotic suppression (CAS) for treatment of Staphylococcus aureus prosthetic joint infection (PJI)
    Rajeshwari Nair, PhD, MBBS, MPH; Marin Schweizer, PhD; Kay M. Tomashek, MD, MPH; Patricia Winokur, MD; Eli Perencevich, MD, MS, FIDSA, FSHEA; Yunshu Zhou, MS; Michihiko Goto, MD, MSCI
    321
    Assessing the Role of Daptomycin as Antibiotic Therapy for Staphylococcal Prosthetic Joint Infection
    Andy Miller, MD; Celeste Russell, MPH; Allina Nocon, PhD; Geoffrey Westrich, MD; Barry Brause, MD; Michael Henry, MD
    Posters
  • Final - Daptomycin.pdf (323.2 kB)
  • 322
    Joint Spacer Retention, Antimicrobial Suppression and Risk of Re-infection
    Jose Carlo Valencia, MD; Douglas Osmon, MD; Matthew Abdel, MD; Raymund R. Razonable, MD, FIDSA
    Posters
  • Valencia_322.pdf (1.0 MB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.